Free delivery from 4,000,000 VND.Details
RU

Metabolic signaling research

Retatrutide

Triple-agonist metabolic peptide

Format15 mg
Price2,200,000 VND ≈ $87
StatusIn stock
Format
Choose your orderYour total updates instantly

Free delivery from 4,000,000 VND

Retatrutide reconstitution calculator

  • Labeled vial
  • Swabs + syringe
  • Written confirmation
Order in Telegram
  • COA tested
  • Confirmed before payment

Research use only

Retatrutide photo 1 01
Retatrutide photo 2 02
Retatrutide photo 3 03
Free with every order Alcohol swabs + mixing syringe
2+ peptides = free bac water 10 ml bacteriostatic water on the house
EN · RU · VI support Order in the language that suits you
Customer message after a VietPeptide delivery in Hoi An
Real order context

Know the details before payment.

For Retatrutide, the selected format, availability and delivery timing are confirmed in advance.

  • Availability before payment
  • Final amount in writing
  • English and Russian support
Ask
Research map

What is Retatrutide?

An investigational peptide that hits three metabolic receptors at once.

ClassMetabolic signaling research
Formats15 mg · 10 mg
Type Synthetic peptide, multi-receptor agonist
Targets GLP-1, GIP and glucagon receptors
Origin Eli Lilly; investigational, in clinical trials
Published research Open PubMed

Retatrutide is a synthetic peptide developed by Eli Lilly and still in clinical trials. It is not an approved medicine anywhere. Its distinguishing feature is that a single molecule activates three receptors: GLP-1, GIP and glucagon. Most metabolic peptides hit one or two.

What published work investigates
01

Triple receptor agonism (GLP-1 / GIP / glucagon)

02

Energy expenditure and metabolic signalling

03

Comparative research against dual-agonist peptides

A vial format is not a use regimen. Clinical and preclinical evidence answer different questions: use the source record above to see the context.

Listed for non-clinical research only. Not for human use.

Format and price

Available options.

Format 15 mg 2,200,000 VND ≈ $87 Final availability is confirmed before payment
Format 10 mg On request Manager confirms availability and final amount
Certificate of analysis

See the lab analysis.

The certificate of analysis for this material: HPLC identity, mass spectrum and amino-acid content for the batch, marked test-qualified. Tap a page to open it full-size. Research use only.

Retatrutide certificate of analysis, page 1
Certificate of analysis, page 1 · Open full-size
Retatrutide certificate of analysis, page 2
Certificate of analysis, page 2 · Open full-size
FAQ

Retatrutide

What is Retatrutide?

A synthetic investigational peptide that activates the GLP-1, GIP and glucagon receptors simultaneously. It was developed by Eli Lilly and remains in clinical trials, it is not an approved medicine. Listed here as a non-clinical research material only.

How is Retatrutide different from Tirzepatide?

Tirzepatide is a dual agonist: it targets GLP-1 and GIP. Retatrutide adds a third target, the glucagon receptor. That extra arm is the main reason the two are compared in metabolic research.

How do I check Retatrutide availability?

Tap “Order in Telegram.” A short message opens with Retatrutide 15 mg / 10 mg. Send it to check availability.

Can I pay directly on the website?

No. After confirmation, payment is accepted in VND or USD.

Still deciding?

Ask about Retatrutide in one message.

The prepared message already includes the product name and selected format.

Ask in Telegram